References
- AROME (2011). Guidelines, minimal requirements and standard of cancer care around the Mediterranean Area: Report from the Collaborative AROME (Association of Radiotherapy and Oncology of the Mediterranean Area). Crit Rev Oncol/Hematol, 78, 1-16. https://doi.org/10.1016/j.critrevonc.2010.03.007
- Bray FI, Weiderpass E (2010). Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007. Int J Cancer, 126, 1454-66.
- Centers for Disease Control and Prevention (2007). Best Practices for Comprehensive Tobacco Control Programs-2007. Atlanta, GA: US Department of Health and Human Services. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2007.
- Crowell RE, Goetz T, Wiggins C, et al (2007). Regional disparities in treatment and survival of early stage non-small cell lung cancer. Ethn Dis, 17, 358-64.
- Demeter SJ, Jacobs P, Chmielowiec C, et al (2007). The cost of lung cancer in Alberta. Can Respir J, 14,81-6.
- Esnaola NF, Lazarides SN, Mentzer SJ, et al (2002). Outcomes and cost-effectiveness of alternate staging strategies for nonsmall- cell lung cancer. J Clin Oncol, 20, 263-73. https://doi.org/10.1200/JCO.20.1.263
- Ezzati M, Henley SJ, Lopez AD, et al (2005). Role of smoking in global and regional cancer epidemiology: current patterns and data needs. Int J Cancer, 116, 963-71. https://doi.org/10.1002/ijc.21100
- Ferlay J, Bray F, Pisani P, et al (2001). Globocan 2000: cancer incidence, mortality and prevalence worldwide, version 1.0.IARC Cancer Base No 5. Lyon: IARC Press.
- Huxley R, Jamrozik K, Lam TH, et al (2007). Impact of smoking and smoking cessation on lung cancer mortality in the Asia Pacific region. Am J Epidemiol, 165, 1280-6. https://doi.org/10.1093/aje/kwm002
- Jemal A, Bray F, Melissa M, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Macbeth FR, Abratt RP, Cho KH, et al (2007). Lung cancer management in limited resource settings: guidelines for appropriate good care. Radiother Oncol, 82,123-31. https://doi.org/10.1016/j.radonc.2006.12.006
- Mackay J, Eriksen M, Shafey O (2006). The Tobacco Atlas. 2nd ed. Atlanta, GA: American Cancer Society.
- McCarthy M, Datta P, Khachatryan A, et al (2008). Would compliance with cancer care standards improve survival for breast, colorectal and lung cancers? J Epidemiol Community Health, 62, 650-4. https://doi.org/10.1136/jech.2007.066258
- National Institute for Health Clinical Excellence (2007). The guidelines man- ual. London: National Institute for Health and Clinical Excellence.
- Nejjari C, Benjelloun MC, Berraho M, et al (2009). Prevalence and demographic factors of smoking in Morocco. Int J Public Health, 54, 447-51. https://doi.org/10.1007/s00038-009-0082-2
- Oliver E, Killen J, Kiebert G, et al (2001). Treatment pathways, resource use and costs in the management of small cell lung cancer. Thorax, 56, 785-90. https://doi.org/10.1136/thorax.56.10.785
- Ou SH, Ziogas A, Zell JA (2009). Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity. J Thorac Oncol, 4, 37-43. https://doi.org/10.1097/JTO.0b013e31819140fb
- Parkin DM (2001). Global cancer statistics in the year 2000. Lancet Oncol, 2, 533-43. https://doi.org/10.1016/S1470-2045(01)00486-7
- Parkin DM, Pisani P, Ferlay J (1999). Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 80, 827-41. https://doi.org/10.1002/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P
- Pentheroudakis G, Stahel R, Hansen H, et al (2008). Heterogeneity in cancer guidelines: should we eradicate or tolerate? Ann Oncol, 19, 2067-78. https://doi.org/10.1093/annonc/mdn418
- Rawaf S, Dubois E, Khatib OM et al (2006). Cancer prevention and control in. Eastern Mediterranean region. BMJ, 333, 860-1.
- Registry of tumors in Great Casablanca region (2004). Annual Report. Casablanca.
- Shafey O, Eriksen M, Ross H, et al (2009). The Tobacco Atlas. 3rd ed. Atlanta, GA:American Cancer Society.
- Smith TJ, Hilnner BE (2001). Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol, 19, 2886-97.
- Tazi MA, Abid-Khalil S, Chaouki N (2003). La prevalence des facteurs de risque cardiovasculaires au Maroc : resultats d'une étude nationale 2000. J Hypertens, 21, 897-903. https://doi.org/10.1097/00004872-200305000-00013
- Vergnenegre A, Molinier L, Chouaid C (2001). Economic analyses and lung cancer. Monaldi Arch Chest Dis, 56, 336-43.
- Youlden DR, Cramb SM, Baade PD (2008). The International Epidemiology of Lung Cancer:geographical distribution and secular trends. J Thorac Oncol, 3, 819-831. https://doi.org/10.1097/JTO.0b013e31818020eb
Cited by
- Costs During the First Five Years Following Cancer Diagnosis in Korea vol.13, pp.8, 2012, https://doi.org/10.7314/APJCP.2012.13.8.3767
- Staging with PET-CT in Patients with Locally Advanced Non Small Cell Lung Cancer is Superior to Conventional Staging Methods in Terms of Survival vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3743
- The Economic Burden of Cancer in Korea in 2009 vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1295
- Cost of Pediatric Visceral Leishmaniasis Care in Morocco vol.11, pp.6, 2016, https://doi.org/10.1371/journal.pone.0155482
- Estimated costs of advanced lung cancer care in a public reference hospital vol.51, pp.0, 2017, https://doi.org/10.1590/s1518-8787.2017051006665
- The prevalence of chronic pain in developing countries vol.3, pp.2, 2013, https://doi.org/10.2217/pmt.12.83